EyeOP1 is an high-intensity focused ultrasound device that is the first non-invasive treatment for glaucoma in China.
Eye Tech Care SA, a French medical device company, received CFDA approval to begin marketing its EyeOP1® glaucoma treatment product in China. EyeOP1 is an high-intensity focused ultrasound device that is the first non-invasive treatment for glaucoma in China. It treats the disease in a three-minute session that has little risk of side effects. In early 2016, Eye Care Tech raised $27 million in funding from China’s Everpine Capital to support China development of the device.
